MLIC
EDSA icon

Mandatum Life Insurance Company’s Edesa Biotech EDSA Stock Holding History

Mandatum Life Insurance Company’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1
Closed -$3K – 217
2015
Q4 		$3K Buy
+1
New +$2.32K ﹤0.01% 300

Other funds holding EDSA

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return

Mandatum Life Insurance Company's EDSA Position: Q1 2016 in Review

Mandatum Life Insurance Company sold out of Edesa Biotech (EDSA) in Q1 2016, closing a stake of 1 share — an estimated $3K sold.

Mandatum Life Insurance Company first reported a position in EDSA in Q4 2015 and held it in 1 quarter. The position peaked at $3K in Q4 2015. 15 funds tracked by Wall St. Rank hold EDSA as of Q1 2016.

  • Mandatum Life Insurance Company reported no remaining Edesa Biotech position as of Q1 2016 after selling out during the quarter.
  • Mandatum Life Insurance Company sold 1 Edesa Biotech share in Q1 2016, an estimated $3K.
  • Mandatum Life Insurance Company first reported a position in Edesa Biotech in Q4 2015 and held it in 1 quarter.
  • Mandatum Life Insurance Company's Edesa Biotech position peaked at $3K in Q4 2015.
  • 15 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2016.

Based on Mandatum Life Insurance Company's 13F filing for Q1 2016, filed 11 May 2016.